SBI Healthcare Opportunities Fund · Direct · Growth
NAV
₹623.7185
as of 16 Nov 2026
Expense Ratio
0.99%
Lumpsum returns (CAGR)
- 1Y
- +25.09%
- 3Y
- +24.54%
- 5Y
- +20.29%
- Since Inception
- +18.36%
SIP returns (XIRR)
- 1Y
- +35.26%
- 3Y
- +21.19%
- 5Y
- +23.70%
- Since Inception
- +18.14%
Performance Comparison
Sectoral allocation
as of 31 Oct 2026- Pharmaceuticals & Biotechnology61.75%
- Healthcare Services29.38%
- Chemicals & Petrochemicals4.39%
- Healthcare Equipment & Supplies1.53%
Each sector links to the mutual funds most exposed to it.
Thinking about SBI Healthcare Opportunities Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH
- 1Sun Pharmaceutical Industries Ltd.10.55%
- 2Divi'S Laboratories Ltd.8.38%
- 3Max Healthcare Institute Ltd.4.96%
- 4Acutaas Chemicals Ltd.4.95%
- 5Apollo Hospitals Enterprise Ltd.4.87%
- 6Laurus Labs Ltd.4.76%
- 7Cipla Ltd.4.36%
- 8Torrent Pharmaceuticals Ltd.4.11%
- 9Aurobindo Pharma Ltd.3.10%
- 10Gland Pharma Ltd.3.06%
What this fund does
SBI Healthcare Opportunities Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
SBI Healthcare Opportunities Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by SBI Mutual Fund. The fund has been operational for over 13 years. It benchmarks its performance against BSE HEALTHCARE TRI. The current expense ratio is 0.99%.